Gastroenterology clinical trials recruiting in Illinois

57 recruiting gastroenterology trials match in Illinois. Showing 20.

• Non-Invasive Quantification of Liver Health in NASH (N-QUAN)Recruiting

  N/A · Perspectum · Chicago, Illinois

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Morton, Illinois

• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Park Ridge, Illinois

• A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Rivus Pharmaceuticals, Inc. · Chicago, Illinois

• Abbott Cephea Mitral Valve Disease RegistryRecruiting

  N/A · Abbott Medical Devices · Chicago, Illinois

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Evanston, Illinois

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting

  Phase 2 · Genentech, Inc. · Chicago, Illinois

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 2 · Eli Lilly and Company · Los Angeles, California

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Des Plaines, Illinois

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Tuscaloosa, Alabama

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Gurnee, Illinois

• Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesRecruiting

  Phase 2 · Northwestern University · Chicago, Illinois

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruiting

  Phase 2 / Phase 3 · Bristol-Myers Squibb · Loma Linda, California

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · Chicago, Illinois

• Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHRecruiting

  Phase 2 · Madrigal Pharmaceuticals, Inc. · Chicago, Illinois

• STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological RemissionRecruiting

  N/A · University of Chicago · Chicago, Illinois

• Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) SymptomsRecruiting

  N/A · Gerd Care Medical Ltd · Afula

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Chicago, Illinois

• A Study to Test Whether BI 3032950 Helps People With Ulcerative ColitisRecruiting

  Phase 2 · Boehringer Ingelheim · Gurnee, Illinois

• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Park Ridge, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.